艾迪药业(688488.SH)：使用不超1亿元暂时闲置募集资金进行现金管理

Core Viewpoint - The company, Aidi Pharmaceutical (688488.SH), has approved a proposal to utilize temporarily idle raised funds for cash management, with a maximum amount of up to 100 million RMB [1] Group 1: Company Actions - The company will use idle raised funds for cash management, with a maximum limit of 100 million RMB [1] - The authorization for using these funds is valid for 12 months, from April 14, 2026, to April 13, 2027 [1] - The company can roll over the use of these idle funds within the specified limit and timeframe [1]